The George Institute For Global Health
United Kingdom

News and Events

National Secondary Prevention Alliance formed to reform health practices in cardiac care.

Media release: 

More than 40 of Australia’s leading experts on injury prevention and safety promotion are gathering in Sydney today, focussing on injury prevention in Aboriginal and Torres Strait Islander communities.

Every Australian will be affected by a serious illness in some way throughout their lives either personally or through friends and family. By participating in Cook for a Cure, Australians have the opportunity to support the prevention, treatment, care and ultimately cure for diseases affecting the Australian community.

The newsletter features a round up of the Fourth Forum on Non-Communicable Disease (NCD) Management, news from the China International Center for Chronic Disease Prevention and an article on the recent visit to Beijing by NCD Experts. Download the latest China Health Focus newsletter.

It's something most parents have to deal with at some stage - putting those learner plates on the car and taking off with your child at the wheel.

Media release: 

Older Australians can improve their balance and mobility with yoga, as reported in a study of Australian participants aged between 59 and 87.

On the 3rd July 2013 The George Institute for Global health in China had the honor of hosting Professor Norbert Berend, Professor Emeritus at the University of Sydney and Head of Respiratory Research at the George Institute for Global Health. Professor Berend presented on chronic obstructive pulmonary disease (COPD) and comorbidities.

Wednesday, 3 July, 2013 - 09:30 to 10:30

The George Institute for Global Health at Peking University Health Science Center
Seminar Room, Level 18

Manoj Saxena, Research Fellow in the Division of Critical Care and Trauma at The George Institute, PhD student, and Intensive Care Physician at St George Hospital in Sydney talks about why being a researcher and clinician is important to him.

The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee has recommended the suspension of marketing of intravenous resuscitation fluids containing hydroxyethyl starch (HES).